Subscribe to World Briefings's newsletter

News Updates

Let's join our newsletter!

Do not worry we don't spam!

FDA Approves Cobenfy: First New Schizophrenia Treatment in 70 Years

Health

27 Sep, 2024

FDA Approves Cobenfy: First New Schizophrenia Treatment in 70 Years


The U.S. Food and Drug Administration (FDA) on Thursday approved Bristol Myers Squibb’s (BMY) highly anticipated schizophrenia drug, Cobenfy. It’s...

Newsletter
Subscribe to Newsletter

Stay Tuned With Updates